J. Brad Chaires, PhD


James Graham Brown Foundation Endowed Chair of Cancer Biophysics; Professor of Medicine; Director, Biophysics Core Facility, James Graham Brown Cancer Center

Research Program
Structural Biology

Education
B.A., University of California at Santa Cruz, Biology, 1972
Ph.D., University of Connecticut, Biophysics, 1978
Postdoctoral Fellow, Yale University, Biophysical Chemistry, 1978-1981

Research and Professional Experience
1979-1981
Department of Medicine, Yale University, NIH Postdoctoral Fellow

1982
Full Member of Graduate Faculty, Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS

1982-1986
Assistant Professor, Department of Biochemistry, University of Mississippi Medical Center, Jackson

1986-1990
Associate Professor, Department of Biochemistry, University of Mississippi Medical Center, Jackson

1987
Tenured, Department of Biochemistry, University of Mississippi Medical Center, Jackson

1989-1990
Visiting Scientist, Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry

1990-2004
Professor, Department of Biochemistry, University of Mississippi Medical Center, Jackson

2000-present
Professor, Joint Appointment, Department of Chemistry, University of Mississippi, Oxford

2004-present
James Graham Brown Endowed Professor of Biophysics, Division of Hematology-Oncology, University of Louisville, Louisville, KY

2004-present
Professor with tenure, Department of Medicine, University of Louisville

2004-present
Senior Scientist, James Graham Brown Cancer Center, University of Louisville

Selected Awards and Professional Honors
1968
President's Scholar, University of California

1989-1990
Alexander von Humboldt Fellow

1991-1992
Member, National Science Foundation Advisory Panel for the Biophysics Program

1996
Basic Science Teacher Award, University of Mississippi School of Dentistry

1997-2001
Chartered Reviewer, NIH, Molecular and Cellular Biophysics Study Section

2000
Outstanding Chemist, Mississippi Section of the American Chemical Society

2000, 2003
Member, National Cancer Institute Program Project Grant Site Visit Team

2000
Member, Committee of Visitors for the Biomolecular Structure and Function and Biomolecular Processes Clusters, Division of Molecular and Cellular Biosciences, National Science Foundation

2004
Chairperson, NIH Bioengineering Research Partnership Review Panel ZRG1 BST-A(50)

Research Interest

Physical biochemistry, drug-DNA interactions, high-throughput screening

My research interests are in the physical biochemistry of nucleic acids and their interactions. We use spectroscopic and calorimetric methods to measure the thermodynamics of nucleic acid binding interactions and to study the stability of nucleic acid structures. Small molecules that bind selectively to particular nucleic acid structures (triplexes, quadruplexes) are of particular current interest. In addition, we are actively interested in the development of enabling biophysical technologies for the rapid screening of drug-nucleic acid interactions. A novel competition dialysis assay was invented to screen small molecule libraries against an array of defined nucleic acid sequences and structures. This technology will enable us to better define nucleic acids as molecular targets for small molecule therapeutics.

Publications
Qu X, Chaires JB.  Analysis of drug-DNA binding data.  in: Numerical Computer Methods, Part C, Method in Enzymology, Vol. 321, (L Brand, MJ Johnson, eds.), Academic Press, Inc., pp. 353-69, 2000

Haq I, Jenkins T, Chowdhry BZ, Jinsong Ren, Chaires JB.  Parsing the free energy of drug-DNA interactions. In:  Energetics of Biological Macromolecules, Part C, Methods in Enzymology, Vol. 323, (MJ Johnson, GK Ackers, eds.), Academic Press, Inc., pp. 373-405, 2000

Ren J, Chaires JB.  Preferential binding of 3,3’-diethyloxadicarbocyanine to triplex DNA.  J Am Chem Soc (Communication) 122:424-5, 2000

Ren J, Bailly C, Chaires JB.  NB-506, an indolcarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA.  FEBS Lett 470:355-9, 2000

Ren J, Jenkins TC, Chaires JB.  Energetics of intercalation reactions.  Biochemistry 39:8439-47, 2000

Qu X, Trent JO, Fokt I, Priebe W, Chaires JB.  Allosteric, chiral-selective drug binding to DNA.  Proc Natl Acad Sci USA 97:12032-7, 2000

Bailly C, Goossens JF, Laine W, Anizon F, Prudhomme M, Ren J, Chaires JB.  Formaldehyde cross-linking of a 2’-aminoglucose Rebeccamycin derivative to both A-T and G-C base pairs in DNA.  J Medic Chem 43:4711-20, 2000

Dignam JJ, Qu X, Chaires JB.  Equilibrium unfolding of Bombyx mori glycyl-tRNA synthetase.  J Biol Chem 276:4028-37, 2001

Chaires JB.  Analysis and interpretation of ligand-DNA binding isotherms.  In: Drug-Nucleic Acid Interactions, Methods in Enzymology, Vol. 340, (JB Chaires, MJ Waring, eds.), Academic Press, Inc., pp. 3-22, 2001

Ren J, Chaires JB.  Rapid screening of structurally selective ligand binding to nucleic acids.  Ibid., pp. 99-108

Priebe W, Fokt I, Przewloka T, Chaires JB, Portugal J, Trent JO.  Exploiting the anthracycline scaffold for designing DNA targeting agents.  Ibid., pp. 529-55

Ren J, Qu X, Dattagupta N, Chaires JB.  Molecular recognition of a RNA:DNA hybrid structure.  J Am Chem Soc 123:6742-3, 2001

Murr MM, Harting MT, Guelev V, Ren J, Chaires JB, Iverson BL.  An octakis-intercalating molecule. Bioorganic Medicinal Chem 9:1141-8, 2001

Alberti P, Ren J, Teulade-Fichou MP, Guittat L, Riou JF, Chaires JB, Helene C, Vigneron JP, Lehn JM, Mergny JL.  Interaction of an acridine dimer with DNA quadruplex structures.  J Biomolec Struct Dynam 19:505-13, 2001

Contact Information

CTR Building
505 South Hancock Street
Louisville, KY 40202

(502) 852-1172



Fax: (502) 852-1153